This tumor type (encompassing basal-like-1 and −2, immunomodulatory, mesenchymal, mesenchymal stem-like, luminal androgen receptor or unspecified) has very high rates of tumor recurrence and poor prognosis compared to other breast cancer subtypes [3–6]. The gene discussed is AR; the disease is neoplasm.